Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-06 Sale |
2021-08-10 8:00 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $138.52 | $3,462,926 | 132,891 (Direct) |
View |
2021-08-04 Sale |
2021-08-06 8:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $128.78 | $3,863,469 | 282,885 (Direct) |
View |
2021-07-19 Sale |
2021-07-21 5:21 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $126.43 | $1,264,348 | 498,558 (Indirect) |
View |
2021-06-30 Sale |
2021-07-01 5:43 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $165 | $4,125,000 | 573,007 (Direct) |
View |
2021-06-29 Sale |
2021-06-30 6:41 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
47,536 | $149.49 | $7,106,341 | 1,581,188 (Indirect Direct) |
View |
2021-06-28 Sale |
2021-06-30 6:38 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,375 | $152.48 | $4,631,583 | 158,831 (Indirect Direct) |
View |
2021-06-28 Sale |
2021-06-30 5:33 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $156.55 | $3,913,750 | 598,007 (Direct) |
View |
2021-06-21 Sale |
2021-06-23 5:54 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $128.62 | $3,215,458 | 623,007 (Direct) |
View |
2021-06-15 Sale |
2021-06-17 5:44 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $126.43 | $3,792,804 | 251,052 (Direct) |
View |
2021-06-11 Sale |
2021-06-15 4:41 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $126.61 | $1,266,118 | 1,575,335 (Indirect Direct) |
View |
2021-03-23 Sale |
2021-03-25 5:39 pm |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
100,000 | $128.05 | $12,805,240 | 122,716 (Direct) |
View |
2021-03-22 Sale |
2021-03-24 6:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,374 | $132.37 | $4,020,667 | 1,585,335 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
80,000 | $0 | 301,335 (Direct) |
View |
2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
37,818 | $69.17 | 301,335 (Direct) |
View |
2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
26,667 | $0 | 35,658 (Direct) |
View |
2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
11,185 | $69.17 | 35,658 (Direct) |
View |
2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
26,667 | $0 | 65,697 (Direct) |
View |
2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
12,607 | $69.17 | 65,697 (Direct) |
View |
2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
13,333 | $0 | 50,209 (Direct) |
View |
2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
6,303 | $69.17 | 50,209 (Direct) |
View |
2021-12-02 Exercise |
2021-12-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
7,342 | $13.62 | 130,144 (Direct) |
View |
2021-12-02 Exercise |
2021-12-03 8:00 pm |
N/A 2027-05-31 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
7,342 | $0 | 130,144 (Direct) |
View |
2021-12-01 Tax Withholding |
2021-12-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $75.1 | 219,153 (Direct) |
View |
2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
10,800 | $0 | 10,800 (Direct) |
View |
2021-10-14 Option Award |
2021-10-18 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
13,800 | $0 | 13,800 (Direct) |
View |
2021-10-15 Exercise |
2021-10-18 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
33,000 | $1.81 | 338,915 (Direct) |
View |
2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
43,000 | $0 | 338,915 (Direct) |
View |
2021-10-15 Exercise |
2021-10-18 8:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
33,000 | $0 | 338,915 (Direct) |
View |
2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
13,800 | $0 | 13,800 (Direct) |
View |
2021-09-13 Tax Withholding |
2021-09-14 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
4,741 | $117.86 | 29,170 (Direct) |
View |
2021-09-10 Exercise |
2021-09-14 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
10,000 | $0 | 29,170 (Direct) |
View |
2021-09-13 Tax Withholding |
2021-09-14 9:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
4,207 | $117.86 | 6,843 (Direct) |
View |
2021-09-10 Tax Withholding |
2021-09-14 9:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
10,000 | $0 | 6,843 (Direct) |
View |
2021-09-10 Exercise |
2021-09-14 9:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
10,000 | $0 | 6,843 (Direct) |
View |
2021-09-01 Tax Withholding |
2021-09-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
787 | $124.83 | 186,932 (Direct) |
View |
2021-08-06 Exercise |
2021-08-10 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $17.75 | 132,891 (Direct) |
View |
2021-03-11 Exercise |
2021-08-10 8:00 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $0 | 132,891 (Direct) |
View |
2021-08-04 Exercise |
2021-08-06 8:00 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $0 | 282,885 (Direct) |
View |
2021-08-04 Exercise |
2021-08-06 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $12.57 | 282,885 (Direct) |
View |
2021-06-28 Other |
2021-06-30 6:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,416,648 | $0 | 1,581,188 (Indirect) |
View |
2021-06-15 Exercise |
2021-06-17 5:44 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $0 | 251,052 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 5:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $12.57 | 251,052 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 6:23 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:39 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:39 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:38 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:37 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:36 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:35 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director |
25,000 | $0 | 25,000 (Direct) |
View |
2021-06-01 Tax Withholding |
2021-06-03 5:34 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $115.8 | 187,719 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,000 | $17.66 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
20,000 | $40.87 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
22,000 | $51.49 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
10,000 | $29.87 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A 2027-06-14 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
88,000 | $0 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,000 | $44.67 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,000 | $14.43 | 122,716 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
1,352 | $124.15 | 36,251 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:50 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
34,360 | $0 | 36,251 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
2,833 | $0 | 36,251 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,526 | $124.15 | 324,498 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:49 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
136,000 | $0 | 324,498 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
11,833 | $0 | 324,498 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
2,141 | $124.15 | 58,384 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:47 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
45,334 | $0 | 58,384 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
4,583 | $0 | 58,384 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,353 | $124.15 | 58,271 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:43 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
34,360 | $0 | 58,271 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
2,833 | $0 | 58,271 (Direct) |
View |